Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003113186 | SCV003791268 | likely benign | Epilepsy, familial adult myoclonic, 5 | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004245946 | SCV004071292 | uncertain significance | not specified | 2023-06-26 | criteria provided, single submitter | clinical testing | The c.1001C>T (p.S334L) alteration is located in exon 9 (coding exon 8) of the CNTN2 gene. This alteration results from a C to T substitution at nucleotide position 1001, causing the serine (S) at amino acid position 334 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |